The Patent Trial and Appeal Board (PTAB) Reverses 35 U.S.C. § 101 Subject Matter Eligibility Rejection of Receptor-Derived Peptide Claims
PTAB Affirms §101 Rejection of Psilocybin Composition, Post-Appeal Prosecution Results in Granted Patent
PTAB Finds that Psilocybin Formulation Is Not a Product of Nature, Further Prosecution Leads to Issued Patent
PTAB Affirms §101 Rejection of Human Milk Product Claims
Patent Trial and Appeal Board Doubles Down on Natural Products Doctrine in Human Milk Case
PTAB Reverses §101 Rejection of Cannabis Composition Claims
Patent Trial and Appeal Board Finds That Cannabis Delivery System Is Not a Natural Product
PTAB Affirms § 101 Rejection of Synthetic Milk Sugar Mixture
The Patent Trial and Appeal Board recently affirmed the 35 U.S.C. § 101 rejection of patent claims for a mixture of three human milk oligosaccharides (HMOs), finding the mixture to be ineligible for patenting
PTAB Reverses §101 Rejection of Probiotic + Prebiotic Composition Claims
Patent Trial and Appeal Board Finds That Probiotic Formulation Is Not a Product of Nature
PTAB Reverses § 101 Rejection of Formulation Containing Component that Mimics Human Product
PTAB Finds That Base Oil + Essential Oil Formulation is Not a Natural Product
OTC MONOGRAPHS @ FDA | FDA
How to Fight Your Health Insurance Denial With an External Appeal — ProPublica
When a health insurer refuses to pay for your treatment, you may have the right to have the denial reviewed — and potentially overturned — by an independent provider. Here are six steps experts suggest to help you through the external appeal process.
Patent Eligibility of Nature Based Food Products
Nature-Based Food Products May Be Eligible for Patenting Under 35 U.S.C. § 101
Tachyum Defends TPU® Trademark from Infringement by Google TPU | Tachyum
Tachyum® today announced that it is beginning to take steps to defend the use of its registered TPU® trademark.
5 days left to apply! 4 new sponsors, $100k + in cash & credits. 4 tracks: → Computer-use - originator.inc → Autoresearch - cthree.cloud x AIDDA Institute → Drug & protein design - Serova… | Jonty Corrin
5 days left to apply! 4 new sponsors, $100k + in cash & credits. 4 tracks: → Computer-use - originator.inc → Autoresearch - cthree.cloud x AIDDA Institute → Drug & protein design - Serova → Materials design - Polaron + 2 special-prize challenges with Cognition & Modal
The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )
Purpose The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked...
The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )
Purpose The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked...
FDA approves first mRNA-based flu vaccine | CNN
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
Pro Se Plaintiff Caught Hiding Prompt Injections In Court Filings; Responds By Hiding More
There have now been dozens of stories of bad lawyers using AI results in filings, most of which show up in the form of fake case citations. That’s old hat at this point. But how about prompt …
No. 022: Palomar proof registry, autonomous protein design, synthetic consensus - The Hallway Track
The Hallway Track No. 022 - How AI is affecting the practice of science
